A Phase II Study on the Effect of Taurisolo<sup>®</sup> Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study.

Cells · 2022 · PMC9101184 · PMID 35563805

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significancep = 0.083so close (0.05 < p ≤ 0.1)

On the contrary, the observed increase in PaO2 did not reach statistical significance (72.8 ± 14 vs. 77.6 ± 11.4; p = 0.083) ( Figure 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.